[3-imidazo[1,2-b]pyridazin-2-yl-5-(2-methoxyethoxy)phenyl]methanamine;3-[3-imidazo[1,2-b]pyridazin-2-yl-5-(2-methoxyethoxy)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-5-(methylsulfanylmethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-5-(methylsulfonylmethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-1,2,4-oxadiazole-5-carboxamide;2-[3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-1,2,4-oxadiazol-5-yl]acetic acid
C97H79F3N30O14S2 — CID 158687896
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-imidazo[1,2-b]pyridazin-2-yl-5-(2-methoxyethoxy)phenyl]methanamine;3-[3-imidazo[1,2-b]pyridazin-2-yl-5-(2-methoxyethoxy)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-5-(methylsulfanylmethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-5-(methylsulfonylmethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-1,2,4-oxadiazole-5-carboxamide;2-[3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-1,2,4-oxadiazol-5-yl]acetic acid
[3-imidazo[1,2-b]pyridazin-2-yl-5-(2-methoxyethoxy)phenyl]methanamine;3-[3-imidazo[1,2-b]pyridazin-2-yl-5-(2-methoxyethoxy)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-5-(methylsulfanylmethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-5-(methylsulfonylmethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-1,2,4-oxadiazole-5-carboxamide;2-[3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-1,2,4-oxadiazol-5-yl]acetic acid (PubChem CID 158687896) has the molecular formula C97H79F3N30O14S2 and a molecular weight of 2010.02 g/mol. Its IUPAC name is [3-imidazo[1,2-b]pyridazin-2-yl-5-(2-methoxyethoxy)phenyl]methanamine;3-[3-imidazo[1,2-b]pyridazin-2-yl-5-(2-methoxyethoxy)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-5-(methylsulfanylmethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-5-(methylsulfonylmethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-1,2,4-oxadiazole-5-carboxamide;2-[3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-1,2,4-oxadiazol-5-yl]acetic acid.
Molecular Properties
| Compound Name | [3-imidazo[1,2-b]pyridazin-2-yl-5-(2-methoxyethoxy)phenyl]methanamine;3-[3-imidazo[1,2-b]pyridazin-2-yl-5-(2-methoxyethoxy)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-5-(methylsulfanylmethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-5-(methylsulfonylmethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-1,2,4-oxadiazole-5-carboxamide;2-[3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-1,2,4-oxadiazol-5-yl]acetic acid |
|---|---|
| PubChem CID | 158687896 |
| Molecular Formula | C97H79F3N30O14S2 |
| Molecular Weight | 2010.02 g/mol |
| Exact Mass | 2008.58 |
| IUPAC Name | [3-imidazo[1,2-b]pyridazin-2-yl-5-(2-methoxyethoxy)phenyl]methanamine;3-[3-imidazo[1,2-b]pyridazin-2-yl-5-(2-methoxyethoxy)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-5-(methylsulfanylmethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-5-(methylsulfonylmethyl)-1,2,4-oxadiazole;3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-1,2,4-oxadiazole-5-carboxamide;2-[3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-1,2,4-oxadiazol-5-yl]acetic acid |
| SMILES | COCCOc1cc(-c2cn3ncccc3n2)cc(-c2noc(C(F)(F)F)n2)c1.COCCOc1cc(CN)cc(-c2cn3ncccc3n2)c1.CS(=O)(=O)Cc1nc(-c2cccc(-c3cn4ncccc4n3)c2)no1.CSCc1nc(-c2cccc(-c3cn4ncccc4n3)c2)no1.NC(=O)c1nc(-c2cccc(-c3cn4ncccc4n3)c2)no1.O=C(O)Cc1nc(-c2cccc(-c3cn4ncccc4n3)c2)no1 |
| InChI | InChI=1S/C18H14F3N5O3.C16H13N5O3S.C16H11N5O3.C16H13N5OS.C16H18N4O2.C15H10N6O2/c1-27-5-6-28-13-8-11(14-10-26-15(23-14)3-2-4-22-26)7-12(9-13)16-24-17(29-25-16)18(19,20)21;1-25(22,23)10-15-19-16(20-24-15)12-5-2-4-11(8-12)13-9-21-14(18-13)6-3-7-17-21;22-15(23)8-14-19-16(20-24-14)11-4-1-3-10(7-11)12-9-21-13(18-12)5-2-6-17-21;1-23-10-15-19-16(20-22-15)12-5-2-4-11(8-12)13-9-21-14(18-13)6-3-7-17-21;1-21-5-6-22-14-8-12(10-17)7-13(9-14)15-11-20-16(19-15)3-2-4-18-20;16-13(22)15-19-14(20-23-15)10-4-1-3-9(7-10)11-8-21-12(18-11)5-2-6-17-21/h2-4,7-10H,5-6H2,1H3;2-9H,10H2,1H3;1-7,9H,8H2,(H,22,23);2-9H,10H2,1H3;2-4,7-9,11H,5-6,10,17H2,1H3;1-8H,(H2,16,22) |
| InChIKey | IFYWEBXJTMRGMK-UHFFFAOYSA-N |
| XLogP | 14.29 |
| TPSA | 553.21 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 43 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 146 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2010.02 |
| LogP ≤ 5 | 14.29 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 43 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158687896 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.